SAKINAH MOHAMAD

Dr. SAKINAH MOHAMAD

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 August 2022 in Journal of Asthma and Allergy
Verified
Journal Article
Open access
PDF file
Baharudin AbdullahBaharudin Abdullah
Baharudin Abdullah
ALAmir Hamzah Abdul Latiff
Amir Hamzah Abdul Latiff
AMAnura Michelle Manuel
Anura Michelle Manuel
FJFaizah Mohamed Jamli
Faizah Mohamed Jamli
HSHarvinder Singh Dalip Singh
Harvinder Singh Dalip Singh
Ralph MösgesRalph Mösges
Ralph Mösges
The goal of allergic rhinitis (AR) management is to achieve satisfactory symptom control to ensure good quality of life. Most patients with AR are currently treated with pharmacotherapy. However, knowledge gaps on the use of pharmacotherapy still exist among physicians, particularly in the primary care setting, despite the availability of guideline recommendations. Furthermore, it is common for physicians in the secondary care setting to express uncertainty regarding the use of new combination therapies like intranasal corticosteroid plus antihistamine combinations. Inadequate treatment leads to significant reduction of quality of life that affects daily activities at home, work, and school. With these concerns in mind, a practical consensus statement was developed to complement existing guidelines on the rational use of pharmacotherapy in both the primary and secondary care settings.

17 May 2022 in Applied Biochemistry and Biotechnology
Verified
Journal Article
Closed access
PDF file
MAMuhammad Rajaei Ahmad
Muhammad Rajaei Ahmad
Zulhisyam Abdul KariZulhisyam Abdul Kari
Zulhisyam Abdul Kari
MDMahmoud A.O. Dawood
Mahmoud A.O. Dawood
NANik Shahman Nik Ahmad Ariff
Nik Shahman Nik Ahmad Ariff
ZSZETI NORFIDIYATI SALMUNA
ZETI NORFIDIYATI SALMUNA
ASAmran Ahmed Shokri
Amran Ahmed Shokri

1 July 2019 in Asia Pacific Allergy
Verified
Journal Article
Open access
PDF file
SMSAKINAH MOHAMAD
SAKINAH MOHAMAD
SHSuzina Sheikh Ab Hamid
Suzina Sheikh Ab Hamid
AAAhmad Azlina
Ahmad Azlina
NSNorasnieda Md Shukri
Norasnieda Md Shukri
Mohamad S, et al. Asia Pac Allergy. 2019 May;9:e22. https://doi.org/10.5415/apallergy.2019.9.e22

1 January 2020 in Medeniyet Medical Journal
Verified
Journal Article
Open access
VDV Sha Kri Eh Dam
V Sha Kri Eh Dam
SMSAKINAH MOHAMAD
SAKINAH MOHAMAD
IMIrfan Mohamad
Irfan Mohamad
Kimura disease (KD) is a rare chronic benign inflammatory disorder of unknown etiology that is prevalent in Asian males. The head and neck region, especially the parotid glands and cervical lymph nodes, are most commonly affected. Diagnosis is based on clinicopathological features, while radiology findings are nonspecific. Although various treatment strategies have been proposed, there is a high recurrence rate. Combination therapy has been found to produce better results than monotherapy. We present a case of KD with huge parotid and cervical lymph node involvement that was treated with a combination of surgery and corticosteroids administered perioperatively.

3 September 2021 in Multidisciplinary Respiratory Medicine
Verified
Journal Article
Open access
PDF file
Baharudin AbdullahBaharudin Abdullah
Baharudin Abdullah
RRRamiza Ramza Ramli
Ramiza Ramza Ramli
NSNorasnieda Md Shukri
Norasnieda Md Shukri
SMSAKINAH MOHAMAD
SAKINAH MOHAMAD
Background: In primary care, general practitioners (GPs) and pharmacists are at the frontline to identify, classify and manage patients suffering from allergic rhinitis (AR). The Allergic Rhinitis and its impact on Asthma (ARIA) guidelines aid clinicians in disease management by providing evidence-based recommendations. A recently published ASEAN primary care survey demonstrated that the awareness of ARIA guidelines was high among GPs but notably lower in pharmacists. Hence, this study seeks to evaluate the effectiveness of a Boot Camp education initiative in bridging the unmet needs in pharmacist awareness and education.Methods: The boot camp was organised as a virtual event. The participants answered the same questionnaire before (pre-assessment) and immediately after (post-assessment) the boot camp session. Statistical analysis was performed on the data paired between the pre- and post- assessments using SPSS v. 25.0 software.Results: The boot camp survey results showed that second-generation oral antihistamines and allergen avoidance are the most preferred options for AR treatment in pharmacy practice, irrespective of the disease severity. In both pre- and post-assessments, efficacy was ranked as the most important factor considered for choosing an antihistamine and which affects patient adherence. With the boot camp initiative, there was a statistically significant increase in awareness about the patient profiling tool (from 31.6% to 88.2%) and ARIA guidelines (from 40.4% to 91.2%) among the pharmacists (p<0.05). The proportion of pharmacists who were able to identify, classify and refer AR patients was significantly increased in post-assessment (p<0.05). Post the boot camp, among the proportion of pharmacists (91.2%) who were already aware of ARIA, a high percentage of them further agreed that ARIA guidelines were useful in identifying and treating patients with AR, as well as classifying AR, respectively (97.6%, 95.2%, and 93.5%).Conclusions: Based on improvements in knowledge and understanding of disease management post assessment, the Allergic Rhinitis Boot Camp initiative is effective and relevant to pharmacy practice. Outreach programs like this reiterate the emphasis on patient compliance and importance of utilizing ARIA guidelines in pharmacy practice that facilitates better management of AR in primary care.

5 September 2019 in Current Treatment Options in Allergy
Verified
Journal Article
Closed access
PDF file
SHSalina Husain
Salina Husain
FZFarah Dayana Zahedi
Farah Dayana Zahedi
SMSAKINAH MOHAMAD
SAKINAH MOHAMAD
Baharudin AbdullahBaharudin Abdullah
Baharudin Abdullah